This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Congenital Bleeding Disorder or Congenital FVII Deficiency
and you are
This is an observational trial.
You are contributing to medical knowledge about your condition.
Show me locations

The purpose

This study is conducted in Japan. The aim of this observational study is to evaluate the long-term safety and efficacy of activated recombinant human factor VII (NovoSeven®) in subjects with congenital FVII deficiency.

Provided treatments

  • Drug: activated recombinant human factor VII

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT01312636. The sponsor of the trial is Novo Nordisk A/S and it is looking for 36 volunteers for the current phase.
Official trial title:
A Multicentre, Open Label, Observational, Non-interventional Study to Evaluate Safety and Efficacy of NovoSeven® in Patients With Congenital FVII Deficiency - Registry for All Treated Patients